EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.17.3 | Arg | - |
Homo sapiens | |
3.4.17.3 | beta-Ala | weak | Homo sapiens | |
3.4.17.3 | His | weak | Homo sapiens | |
3.4.17.3 | Lys | - |
Homo sapiens | |
3.4.17.3 | Orn | weak | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.17.3 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.17.3 | amniotic fluid | - |
Homo sapiens | - |
3.4.17.3 | fibroblast | foreskin | Homo sapiens | - |
3.4.17.3 | lung | plasma membrane and fibroblasts | Homo sapiens | - |
3.4.17.3 | lung cancer cell | metastatic | Homo sapiens | - |
3.4.17.3 | placenta | microvilli | Homo sapiens | - |
3.4.17.3 | plasma | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.4.17.3 | additional information | - |
assay | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.17.3 | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg + H2O | i.e. bradykinin, removal of C-terminal Arg | Homo sapiens | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe + Arg | - |
? |